BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

874 related articles for article (PubMed ID: 7989930)

  • 21. A randomized study in stage IIIB and IV Hodgkin's disease comparing eight courses of MOPP versus an alteration of MOPP with ABVD: a European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group and Groupe Pierre-et-Marie-Curie controlled clinical trial.
    Somers R; Carde P; Henry-Amar M; Tarayre M; Thomas J; Hagenbeek A; Monconduit M; de Pauw BE; Breed WP; Verdonck L
    J Clin Oncol; 1994 Feb; 12(2):279-87. PubMed ID: 7509381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of total nodal irradiation versus combined sequence of mantle irradiation with mechlorethamine, vincristine, procarbazine, and prednisone in clinical stages I and II Hodgkin's disease: experience of the European Organization for Research and Treatment of Cancer.
    Carde P; Hayat M; Cosset JM; Somers R; Burgers JM; Sizoo W; Meerwaldt JH; Hagenbeek A; Monconduit M; van der Schueren E
    NCI Monogr; 1988; (6):303-10. PubMed ID: 3352775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stage I to IIB Hodgkin's disease: the combined experience at Stanford University and the Joint Center for Radiation Therapy.
    Crnkovich MJ; Leopold K; Hoppe RT; Mauch PM
    J Clin Oncol; 1987 Jul; 5(7):1041-9. PubMed ID: 3598608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MOPP or radiation in addition to ABVD in the treatment of pathologically staged advanced Hodgkin's disease in children: results of the Children's Cancer Group Phase III Trial.
    Hutchinson RJ; Fryer CJ; Davis PC; Nachman J; Krailo MD; O'Brien RT; Collins RD; Whalen T; Reardon D; Trigg ME; Gilchrist GS
    J Clin Oncol; 1998 Mar; 16(3):897-906. PubMed ID: 9508171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pediatric stage IV Hodgkin disease. Long-term survival.
    Bader SB; Weinstein H; Mauch P; Silver B; Tarbell NJ
    Cancer; 1993 Jul; 72(1):249-55. PubMed ID: 7685242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involved-field radiotherapy for patients in partial remission after chemotherapy for advanced Hodgkin's lymphoma.
    Aleman BM; Raemaekers JM; Tomiŝiĉ R; Baaijens MH; Bortolus R; Lybeert ML; van der Maazen RW; Girinsky T; Demeestere G; Lugtenburg P; Lievens Y; de Jong D; Pinna A; Henry-Amar M;
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):19-30. PubMed ID: 17097834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiation therapy versus combination chemotherapy in the treatment of early-stage Hodgkin's disease: seven-year results of a prospective randomized trial.
    Longo DL; Glatstein E; Duffey PL; Young RC; Hubbard SM; Urba WJ; Wesley MN; Raubitschek A; Jaffe ES; Wiernik PH
    J Clin Oncol; 1991 Jun; 9(6):906-17. PubMed ID: 2033427
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The treatment of stage IIIA Hodgkin's disease.
    Lister TA; Dorreen MS; Faux M; Jones AE; Wrigley PF
    J Clin Oncol; 1983 Dec; 1(12):745-9. PubMed ID: 6689424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is combined modality therapy necessary for advanced Hodgkin's disease?
    Mendenhall NP; Bennett CJ; Lynch JW
    Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):583-92. PubMed ID: 9231683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined modality treatment: Outcome in patients with Hodgkin's lymphoma.
    Yadav BS; Sharma SC; Malhotra P; Prakash G
    J Cancer Res Ther; 2020; 16(1):1-6. PubMed ID: 32362601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical stages I and II Hodgkin's disease: a specifically tailored therapy according to prognostic factors.
    Carde P; Burgers JM; Henry-Amar M; Hayat M; Sizoo W; Van der Schueren E; Monconduit M; Noordijk EM; Lustman-Marechal J; Tanguy A
    J Clin Oncol; 1988 Feb; 6(2):239-52. PubMed ID: 2578012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiation dose selection in Hodgkin's disease patients with large mediastinal adenopathy treated with combined modality therapy.
    Elconin JH; Roberts KB; Rizzieri DA; Vermont C; Clough RW; Kim C; Dodge RK; Prosnitz LR
    Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):1097-105. PubMed ID: 11072168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The role of radiotherapy in the treatment of Stage IIIA Hodgkin's disease in children].
    Kanaev SV; Kolygin BA; Malinin AP; Chikrizov SI
    Vopr Onkol; 1986; 32(9):53-6. PubMed ID: 3765524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brief chemotherapy, Stanford V, and adjuvant radiotherapy for bulky or advanced-stage Hodgkin's disease: a preliminary report.
    Bartlett NL; Rosenberg SA; Hoppe RT; Hancock SL; Horning SJ
    J Clin Oncol; 1995 May; 13(5):1080-8. PubMed ID: 7537796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiotherapy of early stages Hodgkin's disease. 10 years experience of the Masaryk Memorial Cancer Institute.
    Petera J; Macharová H; Pohanková R; Malír A; Coupek P; Konecný M; Patera J; Pecina J; Drbal J; Koukalová H; Vásová I
    Neoplasma; 2000; 47(2):129-32. PubMed ID: 10985481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Wide-field radiation therapy alone or with chemotherapy for Hodgkin's disease in relapse from combination chemotherapy.
    Mauch P; Tarbell N; Skarin A; Rosenthal D; Weinstein H
    J Clin Oncol; 1987 Apr; 5(4):544-9. PubMed ID: 3559647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Second malignant tumours in childhood Hodgkin's disease.
    Jenkin D; Greenberg M; Fitzgerald A
    Med Pediatr Oncol; 1996 Jun; 26(6):373-9. PubMed ID: 8614372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dose-response relationship of complementary radiotherapy following four cycles of combination chemotherapy in intermediate-stage Hodgkin's disease.
    Loeffler M; Diehl V; Pfreundschuh M; Rühl U; Hasenclever D; Nisters-Backes H; Sieber M; Tesch H; Franklin J; Geilen W; Bartels H; Cartoni C; Dölken G; Enzian J; Fuchs R; Gassmann W; Gerhartz H; Hagen-Aukamp U; Hiller E; Hinkelbein H; Hinterberger W; Kirchner H; Koch P; Krüger B; Schwarze EW
    J Clin Oncol; 1997 Jun; 15(6):2275-87. PubMed ID: 9196141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized trial of CVPP for three versus six cycles in favorable-prognosis and CVPP versus AOPE plus radiotherapy in intermediate-prognosis untreated Hodgkin's disease.
    Pavlovsky S; Schvartzman E; Lastiri F; Magnasco H; Corrado C; Raslawski E; Cancela ME; Ardaiz MC; Cerutti I; Rosso A; Bruno S; Aranguren PN; Salvarezza A; Donato H; Dibar E; Zirone S
    J Clin Oncol; 1997 Jul; 15(7):2652-8. PubMed ID: 9215837
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Wide-field radiation therapy with or without chemotherapy for patients with Hodgkin disease in relapse after initial combination chemotherapy.
    Uematsu M; Tarbell NJ; Silver B; Coleman CN; Rosenthal DS; Shulman LN; Canellos G; Weinstein H; Mauch P
    Cancer; 1993 Jul; 72(1):207-12. PubMed ID: 7685241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.